exenatide

1 stories · following the connections

Business

ProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist

By Nasdaq OMXJun 12, 2017, 1:00 PM UTC